David Rosenbaum, MD
Urology · Jeffersonville, INNPI 1568596195
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.7%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 39 manufacturers reported payments, led by Procept Biorobotics Corporation at 55.8% of the total. Reporting peaked in 2022 at $19,320 and has fallen 93.7% since, to $1,215 in 2025. Among urology clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 441 payments — averaging $88.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Procept Biorobotics Corporation$22K
- Medtronic$10K
- Teleflex LLC$884
- Atricure, Inc.$851
- Boston Scientific$833
- Johnson & Johnson$771
- plus $4K from 33 others
Across 2 payments — averaging $1184.27 each. An ownership or investment interest held by the physician or an immediate family member.
- Louisville URS Solutions, LLC$2K
What the payments were for
- Consulting fees$20,20852%
- Speaking & faculty fees$2,9798%
- Travel & lodging$1,2713%
- Food & beverage$14,49337%
- Education$1230%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Procept Biorobotics Corporation | 26 | $21,815 |
| Medtronic(2 entities) | 227 | $10,393 |
| Teleflex LLC | 14 | $884 |
| Atricure, Inc. | 3 | $851 |
| Boston Scientific | 21 | $833 |
| Johnson & Johnson | 12 | $771 |
| Sumitomo Pharma America, Inc. | 18 | $364 |
| Novartis | 10 | $263 |
| Urogen Pharma, Inc. | 2 | $241 |
| Myriad Genetic Laboratories, Inc. | 3 | $240 |
| Accord Healthcare, Inc. | 23 | $236 |
| Axonics, Inc. | 2 | $198 |
| Astellas Pharma US Inc | 12 | $179 |
| Pfizer | 8 | $165 |
| Siemens Medical Solutions USA, Inc. | 2 | $156 |
| Stryker | 1 | $144 |
| Blue Earth Diagnostics | 3 | $139 |
| Myovant Sciences Inc. | 11 | $130 |
| Sanara Medtech Inc. | 1 | $123 |
| Biom'up France SAS | 1 | $123 |
| AbbVie | 6 | $112 |
| Bayer | 6 | $98 |
| Antares Pharma, Inc. | 5 | $90 |
| Laborie Medical Technologies Corp. | 1 | $76 |
| Neotract Inc. | 2 | $52 |
| Dendreon Pharmaceuticals LLC | 3 | $49 |
| AstraZeneca | 2 | $45 |
| Rochester Medical Corporation | 1 | $42 |
| Urovant Sciences Inc | 2 | $36 |
| Ferring Pharmaceuticals Inc. | 2 | $36 |
| Biolase, Inc. | 1 | $34 |
| E.r. Squibb & Sons, L.L.C. | 2 | $33 |
| Intuitive Surgical | 1 | $25 |
| Calyxo, Inc. | 1 | $20 |
| Merck | 1 | $19 |
| Progenics Pharmaceuticals, Inc. | 1 | $16 |
| Clarus Therapeutics Inc. | 2 | $14 |
| Zyla Life Sciences, Inc. | 1 | $14 |
| SRS Medical Systems, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AquaBeam Robotic System$21,488
- INTERSTIM$6,647
- SYNERGY ABLATION SYSTEM$642
- UroLift System$470
- Erleada$372
- JELMYTO$241
- Pipeline$202
- 1788$144
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$137
- Bulkamid$135
- Axonics r-SNM System$135
- UroLift$132
- BRAC CDx$132
- CellerateRx$123
- HemoBlast Bellows$123
- GENERAL - THERAPIES$121
- Varian CRYOCARE TOUCH System$117
- REZUM$101
How this compares
$39,073 in reported general payments places this provider in the 90th percentile of 272 urology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 174 | $140,682 |
| GemtesaVibegron | 137 | $113,331 |
| Tamsulosin Hcl | 1,322 | $17,677 |
| Potassium Citrate ErPotassium Citrate | 122 | $10,846 |
| Trospium Chloride | 80 | $7,238 |
| Silodosin | 91 | $6,576 |
| PremarinEstrogens, Conjugated | 14 | $6,103 |
| Finasteride | 419 | $4,937 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 309 | $4,656 |
| Testosterone | 14 | $2,978 |
| Testosterone Cypionate | 96 | $2,184 |
| Doxycycline Monohydrate | 172 | $2,171 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 176 | $2,113 |
| Cefdinir | 121 | $1,650 |
| NitrofurantoinNitrofurantoin Macrocrystal | 39 | $1,542 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $179 | $140,682174 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $364 | $113,331137 claims |
| PfizerPremarin | $165 | $6,10314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 272 urology providers in Indiana.
Other urology in Jeffersonville
- James BailenJeffersonville$143K
- Greg SteinbockJeffersonville$134K
- Ryan MaloneJeffersonville$97K
- William SchmiedJeffersonville$58K
- Barry PechaJeffersonville$50K
- John EiflerJeffersonville$26K
- Ganesh RaoJeffersonville$19K
- Bradley BellJeffersonville$16K
- Aaron BeckerJeffersonville$14K
- Dennis SmithJeffersonville$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.